What is the treatment for endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Infective Endocarditis

The treatment of infective endocarditis requires a prolonged course (4-6 weeks) of bactericidal antibiotics tailored to the causative organism, with consideration for surgical intervention in approximately 50% of cases. 1

Diagnostic Approach Before Treatment

  • Obtain three sets of blood cultures at 30-minute intervals before initiating antibiotics to maximize pathogen identification 1, 2
  • Perform echocardiography promptly in all suspected cases; transesophageal echocardiography (TEE) is more sensitive for detecting complications like aortic root abscesses 3
  • For pediatric patients, transthoracic echocardiography (TTE) has high sensitivity (up to 97%), but TEE is recommended for those >10 years of age weighing >60 kg 3

Antimicrobial Therapy Principles

  • Use bactericidal rather than bacteriostatic antibiotics whenever possible 3
  • Administer antibiotics intravenously to ensure complete bioavailability and high serum concentrations 1
  • Treatment duration depends on the causative organism and whether native or prosthetic valve is involved 3, 1

Organism-Specific Treatment

Streptococcal Endocarditis

  • For penicillin-susceptible streptococci (native valve): Penicillin G or ceftriaxone for 4 weeks 1, 4
  • For penicillin-allergic patients: Vancomycin for 4 weeks 1, 5
  • For prosthetic valve streptococcal endocarditis: Extend treatment to 6 weeks 3

Staphylococcal Endocarditis

  • For methicillin-susceptible S. aureus (native valve): Nafcillin, oxacillin, or cefazolin for 4-6 weeks 1, 6
  • For methicillin-resistant S. aureus: Vancomycin for 6 weeks 1, 5
  • For prosthetic valve staphylococcal endocarditis: Add rifampin throughout treatment and gentamicin for first 2 weeks, with total duration of at least 6 weeks 3, 6, 7

Enterococcal Endocarditis

  • Combination therapy with penicillin/ampicillin plus gentamicin for 4-6 weeks 1, 8
  • For vancomycin-treated enterococcal endocarditis: Extend treatment to 6 weeks 3
  • Aminoglycoside duration can be limited to 2 weeks to reduce toxicity while maintaining efficacy 7, 8

HACEK Organisms

  • Ceftriaxone for 4 weeks in native valve endocarditis and 6 weeks in prosthetic valve endocarditis 1

Non-HACEK Gram-Negative Bacteria

  • Early surgery plus long-term therapy (at least 6 weeks) with bactericidal combinations of beta-lactams and aminoglycosides 3
  • Consider adding quinolones or cotrimoxazole in some cases 3

Fungal Endocarditis

  • Combined antifungal therapy and surgical valve replacement due to high mortality (>50%) 3

Blood Culture-Negative Infective Endocarditis

  • Consult with infectious disease specialist from the Endocarditis Team 3
  • Treatment depends on suspected pathogen (see table below for specific regimens) 3

Empiric Treatment

  • Start empiric therapy promptly after blood cultures are drawn, especially in severely ill patients 1, 2
  • For native valve community-acquired infection: Ampicillin + (flu)cloxacillin/oxacillin + gentamicin 9
  • For penicillin-allergic patients: Vancomycin + gentamicin 9
  • For prosthetic valve or healthcare-associated infection: Vancomycin + gentamicin + rifampin 2

Duration of Therapy

  • Native valve highly susceptible streptococci: 4 weeks 3
  • Native valve staphylococci (susceptible to oxacillin): 4-6 weeks 3
  • Native valve staphylococci (resistant to oxacillin): 6 weeks 3
  • Prosthetic valve staphylococci: At least 6 weeks 3
  • Enterococcal endocarditis: 4-6 weeks 3
  • HACEK endocarditis: 4 weeks for native valve, 6 weeks for prosthetic valve 3, 1

Surgical Considerations

  • Early consultation with cardiac surgery is recommended 1
  • Main indications for surgery include:
    • Heart failure due to valve dysfunction 1
    • Uncontrolled infection (abscess, false aneurysm, fistula, enlarging vegetation) 1
    • Prevention of systemic embolism 1
    • Fungal or multiresistant organism infections 1
    • Persistent positive blood cultures despite appropriate antibiotic therapy 1

Monitoring During Treatment

  • Repeat blood cultures until sterile to assess treatment adequacy 9
  • For patients receiving vancomycin and aminoglycosides, monitor drug levels and renal function weekly 9
  • Repeat echocardiography if there is suspicion of new complications 2

Special Considerations

  • Outpatient parenteral antibiotic therapy may be considered for stable patients after initial hospitalization 3
  • Management by a multidisciplinary "Endocarditis Team" is recommended for complex cases 1
  • For persistent or relapsing S. aureus bacteremia/endocarditis, obtain repeat blood cultures and consider surgical intervention 10

References

Guideline

Endocarditis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Empiric Antibiotic Treatment for Suspected Infective Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic treatment of infective endocarditis.

Annual review of medicine, 1983

Research

A review of current treatment strategies for infective endocarditis.

Expert review of anti-infective therapy, 2021

Research

Optimal therapy for enterococcal endocarditis.

The American journal of medicine, 1984

Guideline

Native Valve Endocarditis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.